Coming 2nd Quarter 2017 Optiscan is delighted to announce the...

Coming 2nd Quarter 2017

Optiscan is delighted to announce the official launch of its 2nd generation Preclinical Research product; ViewnVivo.
ViewnVivo is a miniaturised fluorescence endomicroscope platform that brings the next generation of Optiscan’s incredible imaging capability and flexibility to Preclinical Research.
Users of ViewnVivo can capture high resolution, real-time in vivo images with submicron detail and view them in stunning quality for faster Preclinical Research insights.
ViewnVivo represents a significant improvement to the existing competitor’s product offering in the research market providing major benefits including:

 Stunning image quality
 Interactive and continuously variable imaging depth control
 Greater sensitivity for even better image capture
 Validated capability
 Miniaturised without sacrificing image resolution
 Real-time In Vivo insight
 Flexibility of operation
 No dedicated technician or facility required
 Self-calibration and simplicity ensures immediate usability
 Patented technology
 Acceleration of research capability